However, complete inhibition of ERK1/2 mediated by DUSP6 overexpression did not reduce cardiac hypertrophy after pressure overload stimulation, neuroendocrine agonist infusion, or physiologic exercise stimulation [48]. The gene discussed is MAPK3; the disease is cardiac hypertrophy.